Brain-derived neurotrophic factor Val66Met polymorphism moderates the relationship between impulsivity, negative emotions, and binge drinking intensity in university students.


Journal

Alcohol and alcoholism (Oxford, Oxfordshire)
ISSN: 1464-3502
Titre abrégé: Alcohol Alcohol
Pays: England
ID NLM: 8310684

Informations de publication

Date de publication:
09 Sep 2023
Historique:
received: 21 03 2023
revised: 17 05 2023
accepted: 28 05 2023
medline: 12 9 2023
pubmed: 19 6 2023
entrez: 19 6 2023
Statut: ppublish

Résumé

Studies on the genetic factors involved in binge drinking (BD) and its associated traits are very rare. The aim of this cross-sectional study was to investigate differences in the association between impulsivity, emotion regulation and BD in a sample of young adults according to the rs6265/Val66Met variant in the brain-derived neurotrophic factor (BDNF) gene, a well-known candidate gene in alcohol use disorders. We recruited 226 university students (112 women), aged between 18 and 25 years old, from two centers in France. The participants completed measures related to alcohol consumption, depression severity, state anxiety levels, impulsivity (UPPS-P), and difficulties in emotion regulation [Difficulty in Emotion Regulation Scale (DERS)]. The relationship between the BD score and the clinical characteristics in the BDNF genotype groups was assessed by partial correlation analyses and moderation analyses. The partial correlation analyses showed that, in the Val/Val genotype group, the BD score was positively related to UPPS-P Lack of Premeditation and Sensation Seeking scores. In the Met carriers group, the BD score was positively related to UPPS-P Positive Urgency, lack of Premeditation, lack of Perseverance and Sensation Seeking scores and to Clarity score of the DERS. Moreover, the BD score was positively associated with depression severity and state anxiety scores. The moderation analyses revealed that BDNF Val/Met genotype moderated the relationship between several clinical variables and BD. The results of the present study support the hypothesis of common and specific vulnerability factors regarding impulsivity and emotion regulation difficulties associated with BD according to this BDNF rs6265 polymorphism.

Identifiants

pubmed: 37334438
pii: 7199965
doi: 10.1093/alcalc/agad043
doi:

Substances chimiques

Brain-Derived Neurotrophic Factor 0
BDNF protein, human 7171WSG8A2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

505-511

Subventions

Organisme : Fonds Addict'AIDE Professeur Michel Reynaud
Organisme : Regional Council of Picardie (ALCOOLPREDICT)
Organisme : MILDECA (PREVDROG-11)

Informations de copyright

© The Author(s) 2023. Medical Council on Alcohol and Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Farid Benzerouk (F)

University of Reims Champagne-Ardenne, 51100 Reims, France; Cognition Health Society Laboratory (C2S-EA 6e291), 51100 Reims, France.
Department of Psychiatry, Marne Public Mental Health Institution & Reims University Hospital, 51100 Reims, France.
Institute of Psychiatry and Addictions, Paris, France.
Research Group on Alcohol and Pharmacodependences, INSERM UMRS 1247, University of Picardy Jules Verne, 80054 Amiens, France.

Fabien Gierski (F)

University of Reims Champagne-Ardenne, 51100 Reims, France; Cognition Health Society Laboratory (C2S-EA 6e291), 51100 Reims, France.
Department of Psychiatry, Marne Public Mental Health Institution & Reims University Hospital, 51100 Reims, France.
Institute of Psychiatry and Addictions, Paris, France.
Research Group on Alcohol and Pharmacodependences, INSERM UMRS 1247, University of Picardy Jules Verne, 80054 Amiens, France.

Séverine Lannoy (S)

Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University School of Medicine, Richmond, VA 23298-0126, United States.

Sarah Barrière (S)

Department of Psychiatry, Marne Public Mental Health Institution & Reims University Hospital, 51100 Reims, France.

Franca Schmid (F)

University of Reims Champagne-Ardenne, 51100 Reims, France; Cognition Health Society Laboratory (C2S-EA 6e291), 51100 Reims, France.

Charles-Antoine Papillon (CA)

Research Group on Alcohol and Pharmacodependences, INSERM UMRS 1247, University of Picardy Jules Verne, 80054 Amiens, France.

Hakim Houchi (H)

Research Group on Alcohol and Pharmacodependences, INSERM UMRS 1247, University of Picardy Jules Verne, 80054 Amiens, France.

Elodie DeWever (E)

CRP-CPO Laboratory (EA7273), Jules Verne Picardie University, 80025 Amiens, France.

Véronique Quaglino (V)

CRP-CPO Laboratory (EA7273), Jules Verne Picardie University, 80025 Amiens, France.

Mickael Naassila (M)

Institute of Psychiatry and Addictions, Paris, France.
Research Group on Alcohol and Pharmacodependences, INSERM UMRS 1247, University of Picardy Jules Verne, 80054 Amiens, France.

Arthur Kaladjian (A)

University of Reims Champagne-Ardenne, 51100 Reims, France; Cognition Health Society Laboratory (C2S-EA 6e291), 51100 Reims, France.
Department of Psychiatry, Marne Public Mental Health Institution & Reims University Hospital, 51100 Reims, France.
Institute of Psychiatry and Addictions, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH